Skip to main content

Table 1 Demographic and clinical data of study population

From: Children with respiratory tract infections in Swedish primary care; prevalence of antibiotic resistance in common respiratory tract pathogens and relation to antibiotic consumption

 

Number (%)

Variable

All children with Npha culture (n = 340)

Children with growth of either Pncb and/ or Hic (n = 178)

Children with growth of either PNSPd and/ or beta-lactamase producing Hie and/ or BLNARf (n = 40)

Questionnaire only (n = 82)

Female

162 (48)

92 (52)

14 (35)

41 (50)

Age (0-5 years)

275 (81)

160 (90)

38 (95)

65 (79)

Hospital care last 6 months

11 (3)

7 (4)

2 (5)

1 (1)

Abroad last 3 months

81 (24)

43 (24)

10 (25)

21 (26)

Parents smoking

43 (13)

16 (9)

2 (5)

10 (12)

Day care:

 Attending day care centre

224 (67)

137 (77)

33 (83)

56 (68)

 Attending school

60 (18)

7 (4)

1 (3)

16 (20)

 Home

52 (15)

24 (14)

6 (15)

9 (11)

Respiratory tract disease (asthma/ allergy)

34 (10)

20 (11)

1 (3)

9 (11)

Pneumococcal vaccination:

 Don’t know

94 (28)

40 (22)

9 (23)

30 (37)

 Yes

218 (64)

128 (72)

28 (70)

46 (56)

 No

28 (8)

10 (6)

3 (8)

6 (7)

Number of antibiotic treatments during last 12 months:

  > 3

22 (6)

11 (6)

4 (10)

6 (7)

 1-2

98 (29)

46 (26)

12 (30)

19 (23)

 None

182 (54)

105 (59)

21 (53)

57 (70)

Antibiotic treatment within the last 4 weeks

32 (9)

15 (8)

7 (18)

5 (6)

  1. Missing data were 20% regarding “Number of antibiotic treatments during last 12 months”, similar in all groups. In the other variables missing data were <10% in all groups
  2. aNasopharyngeal culture
  3. b Streptococcus pneumoniae
  4. c Haemophilus influenzae
  5. dpenicillin non-susceptible Streptocuccus pneumoniae
  6. ebeta-lactamase producing Haemophilus influenzae
  7. fbeta-lactamase negative ampicillin resistant Haemophilus influenzae